Document is current
Any future updates will be listed below
-
Authors
Das, Alvin S. https://orcid.org/0000-0003-2313-977X
Mallick, Akashleena
Mora, Samantha A.
Keins, Sophia
Abramson, Jessica R.
Castello, Juan Pablo
Pasi, Marco
Kourkoulis, Christina E.
Rodriguez-Torres, Axana
Warren, Andrew D.
Gökçal, Elif
Viswanathan, Anand
Greenberg, Steven M.
Anderson, Christopher D.
Rosand, Jonathan
Biffi, Alessandro
Gurol, M. Edip
-
Funding
Funding for this research was provided by:
Andrew David Heitman Foundation (1200-236980)
American Heart Association (21SFRN812095)
National Institute of Neurological Disorders and Stroke (NS083711, R01NS114526, 5R01NS096730-04, R01NS103924, U01NS069673, 5R01AG026484)
- License Information
-
More Information
Article History
Received: 17 February 2024
Accepted: 25 April 2024
First Online: 21 May 2024
Declarations
:
: The study protocol was approved by the Massachusetts General Hospital’s institutional review board.
: Informed consent was obtained from all participants or their authorized surrogates.
: Dr. Gurol received research grants to his hospital from AVID, Pfizer and Boston Scientific Corporation. Dr. Anderson has received sponsored research support from Bayer AG and has consulted for ApoPharma. The other authors have no relevant financial or non-financial interests to disclose.
: Alvin S. Das is the guarantor for the study and manuscript.
